Niagara study

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Niagara study

Oct 21, 2024, 16:58 | Blog

NIAGARA study vs. dose-dense MVAC: Chandler Park's discussion with Petros Grivas

Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared…

Oct 10, 2024, 14:16 | Dialogues

NIAGARA Study Insights: Durvalumab and Chemotherapy in Bladder Cancer Treatment | Dr. Petros Grivas

In this episode of OncoDaily, Dr. Petros Grivas joins host Chandler Park to discuss the…

Sep 23, 2024, 15:40 | Insight

Olubukola Ayodele: Honored to take part in the Urothelial Cancer preceptorship by ACE Oncology

Olubukola Ayodele shared a post on LinkedIn: “It was truly an honor to have been…

Sep 20, 2024, 13:37 | Blog

Chandler Park: Outstanding discussion on the Niagara study by Petros Grivas

Chandler Park posted the following on X: “OUTSTANDING balanced discussion of the Niagara study by…

All: 4 Posts: 1 - 100

'

ctDNA after surgery for MMRd tumors can prevent cancer recurrence - Yelena Janjigian at AACR25

'

Top Growing Medical Universities in the Post-Soviet Region – BIGR 2025 Edition

'

Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab

'

POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend

'

10 Caring Notes from Pope Francis on Healthcare

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023